Amerijet International Airlines has completed its IATA CEIV Pharma re-certification for the handling of temperature-controlled healthcare and life science products. IATA’s CEIV Pharma Certification is independently validated and ensures that all certified stakeholders meet or exceed the global standards set forth by IATA Temperature Control Regulations (TCR), European Union Good Distribution Practices (EU GDP), World Health Organization and the United States Pharmacopeia Standards.
The IATA appointed independent assessment focused on the quality assurance processes, operational and technical innovation, risk management, and the preservation of all relevant shipment data along the entire logistics chain. The successful re-certification reaffirms Amerijet’s ability to safely handle high value, time-sensitive, and temperature-controlled pharmaceutical cargo with speed, reliability, and efficiency.
“The pharmaceutical supply chain consists of a historically demand-driven as well as a growing patient-driven model, due to the rise of personalized medicines, which makes speed and traceability even more relevant,” said Amerijet’s Vice President of Airport Operations Rasheme Richardson. “We provide our customers with quality standards through uniformed processes, transparency, and a compliant network.”